Table 1.
Clinicopathological characteristics of considered PDAC, PanNET and AVC
| Variable | PDAC (n = 55) | PanNET (n = 42) | AVC (n = 19)b |
|---|---|---|---|
| Gender | |||
| F | 22 (40%) | 16 (38%) | 10 (53%) |
| M | 33 (60%) | 26 (62%) | 9 (47%) |
| Age (years) | 64.5 ± 10,5 | 51.1 ± 13.65 | 63.4 ± 11.18 |
| (median 67.0) | (median 49.5) | (median 63) | |
| Primary tumor | |||
| T1 | 5 (9%) | 20 (47%) | 3 (15%) |
| T2 | 25 (46%) | 15 (36%) | 6 (30%) |
| T3 | 9 (16%) | 7 (17%) | 9 (45%) |
| T4 | 6 (11%) | 0 (0%) | 0 (0%) |
| an.a. | 10 (18%) | 0 (0%) | 1 (5%) |
| Regional lymph nodes | |||
| N0 | 3 (6%) | 22 (52%) | 7 (35%) |
| N1 | 15 (27%) | 12 (29%) | 7 (35%) |
| N2 | 21 (38%) | 0 (0%) | 4 (20%) |
| n.a. | 16 (29%) | 8 (19%) | 1 (5%) |
| Distant metastasis | |||
| M0 | 38 (69%) | 40 (95%) | 18 (90%) |
| M1 | 11 (20%) | 2 (5%) | 1 (10%) |
| n.a. | 6 (11%) | 0 (0%) | 0 (0%) |
| Clinical stage | |||
| I | 3 (6%) | 11 (26%) | 6 (30%) |
| II | 15 (27%) | 11 (26%) | 0 (0%) |
| III | 20 (36%) | 10 (24%) | 12 (60%) |
| IV | 11 (20%) | 2 (5%) | 1 (5%) |
| n.a. | 6 (11%) | 8 (19%) | 0 (0%) |
| Grade | |||
| G1 | 0 (0%) | 29 (69%) | 2 (10%) |
| G2 | 25 (45.5%) | 13 (31%) | 12 (60%) |
| G3 | 14 (25.5%) | 0 (0%) | 4 (20%) |
| n.a. | 16 (29%) | 0 (0%) | 1 (5%) |
| Lymphovascular invasion | |||
| absent | 1 (2%) | 17 (40.5%) | 3 (15%) |
| present | 38 (69%) | 17 (40.5%) | 15 (75%) |
| n.a. | 16 (29%) | 8 (19%) | 1 (5%) |
| Perineural invasion | |||
| absent | 0 (0%) | 22 (52%) | 5 (25%) |
| present | 39 (71%) | 12 (29%) | 13 (65%) |
| n.a. | 16 (29%) | 8 (19%) | 1 (5%) |
an.a (not available data): patients who did not undergo radical surgery; bOne out of 20 AVCs is represented by an adenomatous lesion with high-grade dysplasia (this case has not been reported in the table)